Moxifloxacin hydrochloride

  Cat. No.:  DC4226   Featured
Chemical Structure
186826-86-8
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Moxifloxacin(Avelox, Avalox) is a fourth generation synthetic fluoroquinolone antibacterial agent.
Cas No.: 186826-86-8
Chemical Name: Moxifloxacin hydrochloride
Synonyms: Moxifloxacin hydrochloride;AVALOX;BAY-12-8039;(1's,6's)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride;1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO- 8-METHOXY-7- [(4AS,7AS)-OCTAHYDRO-6H-PYRROLO[3,4-B]PYRIDIN-6-YL]-4-OXO-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE;1-CYCLOPROPYL-7-[(S,S)-2,8-DIAZA-BICYCLO[4.3.0]NON-8-YL]-6-FLUORO-8-METHOXY-1,4-DIHYDRO-4-OXO-3-QUINOLINE CARBOXYLIC ACID HYDROCHLORIDE;ACTIRA;PROFLOX;MOXIFLOXACIN HCL;Moxifloxacin;Moxifloxacin (Hydrochloride);MOXIFLOXACIN, HYDROCHLORIDE MONOHYDRATE;1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridine-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride;1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-c;Avelox,Avalox;Moxiflaxacin HCL;Moxifloxacin Hydrochloride (200 mg);1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride;Avelox;Actura;BAY12-8039 HCl;MoxifloxacineHCl;盐酸莫西沙星;Vigamox;Izilox;Moxeza;CPD000469185;AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER;C53598599T;DSSTox_RID_81224;DSSTox_CID_25921;DSSTox_GSID_45921;(4aS-cis)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolol(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride;1-Cyclopropyl-6-fluoro-1,4-d;Moxifioxacin hydrochloride;BAY 12-8039;Moxifloxacine Hydrochloride;Moxifloxacin for peak identification;Prasugrel;Moxifloxacin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material;NSC-758875;BCP9000963;CS-1063;M2479;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride; d-Moxifloxacin Hydrochloride; (4R,7R)-Moxifloxacin Hydrochloride;;Moxifloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard;MOXIFLOXACIN HYDROCHLORIDE [ORANGE BOOK];Moxifloxacin hydrochloride (USAN:USP);1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride;MLS001401368;186826-86-8 (HCl); 354812-41-2 (free base);Avelox (TN);3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-, monohydrochloride;MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER;1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid HCl;MOXIFLOXACIN HYDROCHLORIDE [WHO-DD];NSC 758875;Tox21_111439;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1);Octegra;KS-1181;Q27107395;Z2235801869;7-...
SMILES: Cl[H].FC1C([H])=C2C(C(C(=O)O[H])=C([H])N(C2=C(C=1N1C([H])([H])[C@]2([H])[C@@]([H])(C([H])([H])C([H])([H])C([H])([H])N2[H])C1([H])[H])OC([H])([H])[H])C1([H])C([H])([H])C1([H])[H])=O
Formula: C21H25ClFN3O4
M.Wt: 437.8923
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: For the detailed information about the solubility of Moxifloxacin hydrochloride in water, the solubility of Moxifloxacin hydrochloride in DMSO, the solubility of Moxifloxacin hydrochloride in PBS buffer, the animal experiment(test) of Moxifloxacin hydrochloride, the in vivo,in vitro and clinical trial test of Moxifloxacin hydrochloride, the cell experiment(test) of Moxifloxacin hydrochloride, the IC50, EC50 and Affinity of Moxifloxacin hydrochloride , please contact DC Chemicals.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC4226 Moxifloxacin hydrochloride Moxifloxacin(Avelox, Avalox) is a fourth generation synthetic fluoroquinolone antibacterial agent.
DC10161 Gepotidacin Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor.
X